7Z61
Crystal structure of PI3Kgamma with a dihydropurinone inhibitor (compound 18)
Summary for 7Z61
Entry DOI | 10.2210/pdb7z61/pdb |
Descriptor | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform, 9-[(3~{R},4~{R})-4-fluoranylpyrrolidin-3-yl]-7-methyl-2-[(7-methylquinolin-6-yl)amino]purin-8-one (2 entities in total) |
Functional Keywords | type i kinase inhibitor, structure-baed drug design, signaling protein |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 1 |
Total formula weight | 111120.52 |
Authors | Goldberg, F.W.,Ting, A.K.T.,Schimpl, M. (deposition date: 2022-03-10, release date: 2022-07-13, Last modification date: 2024-05-01) |
Primary citation | Goldberg, F.W.,Ting, A.K.T.,Beattie, D.,Lamont, G.M.,Fallan, C.,Finlay, M.R.V.,Williamson, B.,Schimpl, M.,Harmer, A.R.,Adeyemi, O.B.,Nordell, P.,Cronin, A.S.,Vazquez-Chantada, M.,Barratt, D.,Ramos-Montoya, A.,Cadogan, E.B.,Davies, B.R. Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8 H -purin-8-one Inhibitors of DNA-PK. Acs Med.Chem.Lett., 13:1295-1301, 2022 Cited by PubMed: 35978693DOI: 10.1021/acsmedchemlett.2c00172 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.738 Å) |
Structure validation
Download full validation report